From lifelong therapy to intermittent treatment: the future of chronic myeloid leukemia management—commentary on interim results from DAstop2 trial
@article{ACTR10217, author = {Tomáš Horňák and Daniela Žáčková}, title = {From lifelong therapy to intermittent treatment: the future of chronic myeloid leukemia management—commentary on interim results from DAstop2 trial}, journal = {AME Clinical Trials Review}, volume = {2}, number = {0}, year = {2024}, keywords = {}, abstract = {}, issn = {3005-6152}, url = {https://actr.amegroups.org/article/view/10217} }